Vasopressin in septic shock.
Russell
James A
JA
Critical Care Medicine and James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada. jrussell@mrl.ubc.ca
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D009638:Norepinephrine / Q000627:therapeutic use; D017483:Receptors, Vasopressin / Q000378:metabolism; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*
D017483:Receptors, Vasopressin; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D009638:Norepinephrine